Medvarsity Logo
Hypertension: mechanism and approach to target organ protection

CASE DISCUSSION

Hypertension: mechanism and approach to target organ protection

United Arab Emirates flagPresented United Arab Emirates by Dr.Ramkumar Sundaraperumal

Views

9,180

Case Description

Hypertension is a common condition characterized by abnormally high blood pressure levels. The mechanism underlying hypertension involves an increase in peripheral vascular resistance and/or an increase in cardiac output. Several factors can contribute to the development of hypertension, including...

Case Summary

  • Blood pressure is the force exerted by circulating blood on the walls of blood vessels, crucial for maintaining blood circulation throughout the body. It's primarily determined by two key factors: cardiac output (the amount of blood pumped by the heart per minute) and peripheral vascular resistance (the resistance to blood flow in the arteries). Several mechanisms regulate these factors, including the sympathetic nervous system, the renin-angiotensin-aldosterone system, endothelial function, and vasoactive substances.

Speaker Profile

Dr.Ramkumar Sundaraperumal

Dr.Ramkumar Sundaraperumal

HOD and Specialist Internal Medicine, Zulekha hospital, Dubai
Dr. Ramkumar Sundaraperumal is the Head of Department and Specialist in Internal Medicine at Zulekha Hospital Dubai. He has extensive experience in diagnosing and managing a wide range of acute and chronic medical conditions in adult patients. His clinical expertise includes diabetes, hypertension, infectious diseases, and complex multisystem disorders. He is known for his patient-centric approach and emphasis on evidence-based internal medicine practice. Through his leadership role, he contributes to advancing quality healthcare delivery and clinical excellence in hospital medicine.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.